Answers are grounded in this paper and cite their sources.
Reveals that 7-hydroxyaurones protect cardiomyoblasts from simulated hypoxia while modulating HIF-1α expression, suggesting new therapeutic avenues to limit cardiac damage.
Myocardial infarction (MI) is the leading cause of death worldwide. The extent of infarct size, determined by the degree of cardiomyocyte death, is a major factor in post-MI functional recovery. Therefore, cardioprotective strategies focus on limiting infarct size. Among the mechanisms involved in the MI response, Hypoxia Inducible Factor-1 (HIF-1) plays a complex role that can be either beneficial or detrimental depending on the nature of its activation ( i.e., acute or chronic ). Given the potential cardioprotective effects of curcumin through HIF-1 modulation, we investigated the impact of hydroxylated aurone derivatives on cardiomyoblasts (H9C2) incubated with cobalt chloride (CoCl₂, 1 mM for 2 h), which mimics hypoxia by stabilizing HIF-1α. Cell viability was measured using the methyl thiazolyl tetrazolium (MTT) assay, and HIF-1α expression was assessed by western blot. Interestingly, only the three 7-hydroxyaurones enhanced cell viability under CoCl₂-induced stress, showing efficiencies comparable to curcumin (120–140 % improvement at 100 μM). However, they exhibited divergent effects on HIF-1α expression: 2′- and 3′-hydroxyaurones led to a reduction, whereas 4′-hydroxyaurone caused an increase. This study thus identifies a new class of molecules capable of modulating HIF-1 activity and preventing cardiac cell death. These findings open new perspectives, as these aurones could potentially be developed for strategies aiming to reduce infarct size by regulating HIF-1 expression, either increasing HIF-1α in the context of MI alone or suppressing its expression under chronic conditions such as obstructive sleep apnea syndrome (OSA). • Myocardial infarction and heart failure remain leading factors in global mortality. • Preventive treatments are needed to adress the root causes of these pathologies. • HIF-1α is a key in intermittent hypoxia, the main feature of these pathologies. • Aurones modulate HIF-1α expression and therefore intermittent hypoxia.
No takes yet. Share an insight, caveat, or question.
Maria et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: